Company Filing History:
Years Active: 2012-2014
Title: Innovations in Magnetic Nanomedicine by See-Tong Pang
Introduction
See-Tong Pang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of nanomedicine, particularly in the treatment of prostate cancer and tumor suppression. With a total of 2 patents, his work focuses on developing innovative solutions that enhance therapeutic effects through magnetic properties.
Latest Patents
One of his latest patents is titled "Magnetic nanomedicine for inhibiting/treating human prostate cancer." This invention discloses a magnetic nanomedicine that comprises a core containing a magnetic particle with a diameter of less than 10 nm. The shell is made of a carboxylated polyaniline and encapsulates the core, while a medicine is covalently linked to the shell to inhibit or treat prostate cancer. This magnetic nanomedicine not only exhibits superior thermal stability but also has a higher water solubility compared to conventional anti-prostate cancer medicines. Furthermore, it can be magnetically directed to the cancer area, increasing the local concentration of medicine and enhancing the therapeutic effect.
Another significant patent is "Magnetic nanomedicine for tumor suppression and therapy." This invention includes a core made of magnetic nanoparticles and a shell encapsulating the core, which is made of carboxylated polyaniline. The tumor suppression medicine, either Epirubicin or Doxorubicin, is covalently bonded to the shell. This magnetic nanomedicine improves thermal stability and can dissolve uniformly in water. Its superparamagnetic property allows it to be guided by an external magnetic field to concentrate at the tumor site, thereby increasing local medicine concentration and enhancing therapy effects.
Career Highlights
See-Tong Pang is affiliated with Chang Gung University, where he continues to advance research in nanomedicine. His innovative work has positioned him as a key figure in the development of targeted therapies for cancer treatment.
Collaborations
He has collaborated with notable coworkers, including Mu-Yi Hua and Cheng-Keng Chuang, contributing to the advancement of research in his field.
Conclusion
See-Tong Pang's contributions to magnetic nanomedicine represent a significant advancement in cancer treatment. His innovative patents demonstrate the potential for improved therapeutic outcomes through targeted delivery systems.